In line with these observations, abnormalities were identified in the p53 in RA patients; nonetheless, they were not associated with the cancerous characteristics of the rheumatoid synovium, as evaluated by proliferative manifestations [99]. This evidence concerns the gene TP53 and rheumatoid arthritis.